What advice do researchers who have previously done RNA-seq on a non-model organism have ? I have RNA-seq data on sea urchin. The current version of the genome has 174772 contigs. I have so far tried generating a genome index with STAR. It used up all of the RAM, and the author said the mapping performance wasn't good on any genomes with more than 50000 contigs. I have also tried de-novo assembly with Trinity, and the number of genes and isoforms found was unrealistically large. Does anyone have a success story to share ?
Unconfigured Ad
Collapse
X
-
try filtering out contigs that have a FPKM of less than 1, or .5. This should get rid of a large number of, likely junk, contigs. There are tools in Trinity (RSEM or eXpress) to to this.
Also, you could try clustering with cd-hit-est to get rid of redundancy.
-
-
Dear Dario1984,
You may try the Subread aligner which can deal with large number of contigs.
Best wishes,
Wei
Comment
-
-
To avoid RAM problems for the large number of contigs with STAR, try reducing --genomeChrBinNbits (=18 by default) to a smaller number, ~14 or less. The mapping speed will be slow by STAR's standards, but it may still adequate.Originally posted by Dario1984 View PostWhat advice do researchers who have previously done RNA-seq on a non-model organism have ? I have RNA-seq data on sea urchin. The current version of the genome has 174772 contigs. I have so far tried generating a genome index with STAR. It used up all of the RAM, and the author said the mapping performance wasn't good on any genomes with more than 50000 contigs. I have also tried de-novo assembly with Trinity, and the number of genes and isoforms found was unrealistically large. Does anyone have a success story to share ?
Comment
-
-
This paper should be of good reference:Originally posted by Dario1984 View PostThanks for alerting me to the CD-HIT program. I wasn't aware of it. Have you published a journal article using those two steps already ?
Comment
-
-
I used Subread on the data. Because the seed has to be matched exactly, it isn't suitable for mapping to a related organism's genome. 11 % of my reads mapped. I can see it would be great for mapping to a high quality reference genome, such as the human genome sequence.
Comment
-
-
Most of the reads in the Trinity assembly will be background RNA (something like 80% of the genome is transcribed remember) and assembly junk. As mentioned already mapping the reads to the Trinity assembly and excluding low count sequences will remove this junk. I prefer to use raw read count, then you can easily see what portion of reads map to the 20-40K Trinity sequences you are left with. I have done something like that and from 370,000 trinity sequences, 96% of the reads mapped to about 38,000 trinity sequences and the rest were discarded.
Comment
-
-
Hi Dario,Originally posted by Dario1984 View PostI used Subread on the data. Because the seed has to be matched exactly, it isn't suitable for mapping to a related organism's genome. 11 % of my reads mapped. I can see it would be great for mapping to a high quality reference genome, such as the human genome sequence.
Could you please provide a bit more info about your data such as read length, single-end or paired-end etc? There could be many reasons contributing to a low mappability. Although Subread does not allow mismatches in the seeds, these seeds are quite short (16bp), so I do not really think this was the reason you got a low mapping percentage when mapping your reads to a related species.
One thing which may be worthwhile to try is to set -m=1 to test how many reads have a 16bp substring perfectly matched with the reference. If you still got a low percentage, this may simply tell you that your reads are very different from the reference.
Best regards,
Wei
Comment
-
-
What happens if you only take the 50000 biggest contigs from your reference? A lot of times these draft assemblies have many small contigs that aren't going to contain useful information for gene expression analysis anyway. Meaning they will mostly not contain coding regions, or if they do its only one, maybe two exons, and you can't assign orthology anyway.
Comment
-
-
I think the related genome is too distant. I took 100 random reads and used BLAST to get an impression of what the mapping would be like. Two representative examples of one of the 50 base read pairs are
andCode:>Scaffold915 Length = 323013 Score = 42.1 bits (21), Expect = 0.006 Identities = 39/45 (86%) Strand = Plus / Plus Query: 6 ttccagacaaaacagacaacaaatcataatcataaatatcatttg 50 |||| ||||||| |||||||| || |||| |||||||||||||| Sbjct: 261960 ttcctgacaaaatagacaacatttcttaattataaatatcatttg 262004
I will proceed by implementing the filtering strategies for de-novo assembly.Code:>Scaffold476 Length = 632255 Score = 40.1 bits (20), Expect = 0.025 Identities = 20/20 (100%) Strand = Plus / Minus Query: 8 caagaatttttttgatgaaa 27 |||||||||||||||||||| Sbjct: 568677 caagaatttttttgatgaaa 568658
Comment
-
Latest Articles
Collapse
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
Today, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
-
by SEQadmin2
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...-
Channel: Articles
07-08-2026, 05:17 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Today, 11:10 AM
|
0 responses
8 views
0 reactions
|
Last Post
by SEQadmin2
Today, 11:10 AM
|
||
|
Started by SEQadmin2, 07-13-2026, 10:26 AM
|
0 responses
30 views
0 reactions
|
Last Post
by SEQadmin2
07-13-2026, 10:26 AM
|
||
|
Started by SEQadmin2, 07-09-2026, 10:04 AM
|
0 responses
39 views
0 reactions
|
Last Post
by SEQadmin2
07-09-2026, 10:04 AM
|
||
|
Started by SEQadmin2, 07-08-2026, 10:08 AM
|
0 responses
25 views
0 reactions
|
Last Post
by SEQadmin2
07-08-2026, 10:08 AM
|
Comment